Dxn Was Founded By Dr

  • October 2019
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Dxn Was Founded By Dr as PDF for free.

More details

  • Words: 650
  • Pages: 3
value. However, Dr. Lim did not stop there. He believed he should form a company to make known to people about this miraculous herb and the benefits that can be derived from it. In 1993, Dr. Lim's dream came true when he established DXN.

DXN was founded by Dr. Lim Siow Jin, a graduate from the famed Indian Institute of Technology. Dr. Lim Siow Jin has keen interest in mushrooms and their relationship with human health. To better understand this relationship, Dr. Lim has travelled far and wide in search of The King of all Herbs - Lingzhi. After more than twenty years of research and scientific analysis, Dr. Lim finally discovered the benefits of Lingzhi, the king of all herbs, to mankind. Realising the importance and benefits of Lingzhi, Dr. Lim began sharing his knowledge about this miraculous herb with his friends, and they too were greatly impressed with its beneficial medicinal

DXN started from scratch and was initially not well known as a Network Marketing company. However today , DXN is one of the most well known and fastest growing Network Marketing organisations in the world by virtue of the One Dragon, One World, One Market concept.

Today DXN can boast of its world class Lingzhi Farm and GMP standard Pharmaceutical Factory. With operations in over 108 countries, and with over four million registered distributors worldwide, DXN is solidifying its position as the world leader in Lingzhi products.

Lingzhi Farm DXN has owned a 30-acre Ganoderma farm in Bukit Wang and another 10 acres farm in Bukit Pinang, both in Kedah, Malaysia. Both farms boast of several unique and important traits in the cultivation of high quality Ganoderma. These distinctions are:

Market, One Mind

One Dragon, One World, One

“ONE DRAGON” – We undertake the entire process, from cultivation to marketing. “ONE WORLD, ONE MARKET" – Our distributors enjoy worldwide bonus with a single membership card. “ONE MIND” – We are focused on achieving our Global Vision and will strive to help our distributors achieve this vision.

Suitable Climate - warm and humid environment, with temperatures ranging from 26oC to 27oC. Clean Water - with pH maintained between 7.0 and 7.9. Fresh Air - the farms are located away from the populated and polluted areas to ensure that our products are free from toxins. Organic Cultivation - natural materials such as rice chaff and sawdust are used instead of fertiliser, insecticide and steroid. This method produces more than 200 kinds of primary and secondary elements such as enzyme, coenzyme, amino acid, vitamins, carbohydrate and other trace elements which help to improve the crop's quality, quantity, growth and resistance to pests. Tissue Culture Method - one million pieces of Ganoderma are produced from a single mother plant of the highest quality. Suspension Arrangement Method - used to avoid the pervasion of unwanted ingredients into the Ganoderma, thus the growth and quality of Ganoderma are assured.

All the above techniques are exclusively developed by DXN. We are also proud to declare that our Ganoderma plant takes only 3 months from planting to harvest as compared to our rivals which require 6 months or even longer. Our Lingzhi Farm has also received the ISO 14001 Certification.

Pharmaceutical DXN Pharmaceutical Sdn. Bhd., an integrated factory, is another success story for DXN. It is a complete factory with solid infrastructure and up-to-date machines. DXN Pharmaceutical which has "Good Manufacturing Practice" status was officially opened on June 9, 2001. It has an area of 28,000 square feet and is considered as one of the world's finest factories with its up-to-date machines and infrastructure. The factory's facilities are designed to meet world requirement while the latest machines are designed to ensure that our output is at maximum capacity. More than 80% of DXN Pharmaceutical output are for the overseas market.

DXN Pharmaceutical's new complex provides a new dimension to our efforts to ensure high productivity.

Related Documents